7-OH vape products represent a relatively new format within the broader market of kratom-derived and alkaloid products. They differ from traditional powders, capsules, tablets, extracts, and other formulations primarily because they combine concentrated 7-hydroxymitragynine (7-OH) with an inhaled delivery system.

7-OH Compared With Traditional Kratom

Natural kratom (Mitragyna speciosa) contains a complex mixture of alkaloids, with mitragynine generally being the predominant compound. 7-OH occurs naturally in trace amounts, meaning ordinary kratom leaf has a substantially different chemical profile from products specifically formulated around concentrated 7-OH.  

By comparison, research on commercial products has found that many concentrated 7-OH products contain levels and compositions that differ considerably from authentic kratom leaf. One 2026 analytical study found substantial discrepancies between labeled and measured 7-OH amounts in some products.  

Vape Versus Oral Formats

The most important distinction is the route of administration. Tablets, capsules, powders, and many extracts are designed for oral use, whereas vape products deliver an aerosol through inhalation.

This creates additional research questions involving aerosol chemistry, thermal stability, respiratory exposure, and pharmacokinetics. A 2026 publication in Toxicological Sciences specifically identified 7-OH and kratom vaping products as an emerging public-health concern.  

Other Alkaloid Formats

Commercial kratom-derived products now include tablets, films, liquid products, extracts, concentrates, and vaping products. A 2026 study examining 49 nonswallowed kratom-derived products found that 67% were vaping products, while others were sublingual strips or buccal pouches. Most contained 7-OH, although some contained mitragynine extracts or mitragynine pseudoindoxyl.  

These formats should not automatically be treated as interchangeable because their chemical composition and delivery routes can differ substantially.

Why Testing Is Important

For researchers evaluating 7-OH products, laboratory analysis is particularly important. Testing can help establish the actual alkaloid profile, identify unexpected compounds, and determine whether the product composition matches its labeling. Recent research has documented inconsistent labeling and additional unreported compounds in some commercial kratom-derived products.  

Conclusion

7-OH vapes differ from other alkaloid formats through both their chemical composition and inhaled delivery route. Comparing them with traditional kratom leaf or conventional oral products requires consideration of alkaloid concentration, formulation, aerosol chemistry, exposure pathways, analytical testing, and the limited amount of long-term research currently available.